Product image of Willfact (Human Von Willebrand Factor) supplied by GNH India

Willfact

Active Ingredient:
Human Von Willebrand Factor
Origin:
EU

Willfact (Human Von Willebrand Factor)

Willfact (Human Von Willebrand Factor) is a plasma-derived therapy for von Willebrand disease, supporting clotting factor replacement. Used to manage bleeding episodes and surgical prophylaxis in VWD patients. Short-term solution for clotting disorders.

Manufacturer / TM Owner

Lfb Biomedicaments

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Willfact is used to treat and prevent bleeding in patients with von Willebrand disease, a condition where blood does not clot properly. It may also be used before medical procedures to reduce bleeding risk. This therapy replaces missing or defective von Willebrand factor, a protein essential for blood clotting. It is not a cure but helps manage symptoms during active treatment periods.

Side Effects

  • Willfact works by temporarily increasing levels of von Willebrand factor in the bloodstream, which helps blood clot more effectively. Users may notice reduced bleeding episodes or faster clotting during treatment. Effects vary by individual and depend on the condition being managed.

Precautions & Warnings

  • Store Willfact as directed by healthcare providers, typically refrigerated but not frozen. Protect from light and keep out of reach of children. Use only as prescribed and report any unusual reactions. Do not use if the solution is discolored or contains particles. Always follow medical guidance for administration timing and storage.

Avoid Interactions

  • Willfact may interact with other clotting therapies or medications affecting blood viscosity. Avoid alcohol and herbal supplements unless approved by a healthcare professional. Inform providers about all current medications to assess potential interactions. No known severe interactions have been widely reported, but individual responses may vary.

Frequently Asked Questions

Willfact is used to treat and prevent bleeding in people with von Willebrand disease by replacing missing clotting factors.

Willfact is given as an intravenous infusion, typically in a clinical or home setting under medical supervision.

Consult a healthcare provider before using Willfact if pregnant or breastfeeding, as safety may vary by individual.

Common effects may include headache, nausea, or injection site reactions; report persistent issues to a doctor.

No, Willfact is a temporary treatment that helps manage bleeding but does not cure the underlying condition.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Von Willebrand Factor

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT